Trident Lifeline Ltd

Trident Lifeline Ltd has announced that its 13th Annual General Meeting (AGM) will be held on Saturday, September 26, 2026, at 04:00 p.m. IST via Video Conferencing. The company is submitting its Annual Report for FY 2025-26 along with the Notice of AGM, in compliance with SEBI Listing Regulations. The Annual Report is also available on the company's website. A cut-off date of Saturday, September 19, 2026, has been fixed for determining member eligibility for e-voting and attending the AGM. The remote e-voting period will be from Wednesday, September 23, 2026, to Friday, September 25, 2026. The report highlights the company's growth strategy, capabilities, and value chain in the healthcare sector.

Trident Lifeline Ltd announced that its 13th Annual General Meeting (AGM) will be conducted on Saturday, September 26, 2026, at 04:00 p.m. IST. The meeting will be held entirely through Video Conferencing / Other Audio-Visual Means, adhering to guidelines from the Ministry of Corporate Affairs and SEBI. The company has also submitted its Annual Report for the financial year 2025-26, which includes the Notice of AGM. A cut-off date of Saturday, September 19, 2026, has been fixed to determine member eligibility for voting and attendance. The remote e-voting period will commence on Wednesday, September 23, 2026, and conclude on Friday, September 25, 2026.

Trident Lifeline Ltd has announced a revision to its Book Closure period and Cut-off date for remote e-voting and e-voting during the upcoming 13th Annual General Meeting (AGM). The original dates were September 19-26, 2026, with a cut-off of September 18, 2026. The revised Book Closure period is now Sunday, September 20, 2026, to Saturday, September 26, 2026. The new Cut-off Date for remote e-voting and e-voting during the AGM is Saturday, September 19, 2026. All other details remain as per the Board Meeting outcome on August 26, 2026.

Trident Lifeline Ltd has announced the allotment of 24,000 equity shares following the conversion of an equal number of warrants. The conversion was executed at an issue price of ₹266 per share, including a premium of ₹256, resulting in the receipt of ₹47,88,000 from the warrant holder, Ashish Anandsingh Bafna. This allotment increases the company's issued, subscribed, and paid-up equity share capital to ₹11,95,70,000, comprising 11,957,000 equity shares of ₹10 face value each. The newly issued shares will rank pari-passu with existing equity shares.

Trident Lifeline Ltd has announced the allotment of 24,000 equity shares of face value Rs. 10 each, following the conversion of an equal number of warrants. The conversion was executed upon receipt of the remaining 75% of the issue price from the warrant holders. The total amount received for this conversion was Rs. 47,88,000. This allotment increases the company's issued, subscribed, and paid-up equity share capital to Rs. 11,95,70,000, comprising 11,957,000 equity shares. The new shares will rank pari-passu with existing equity shares. One warrant holder, Ashish Anandsingh Bafna, was involved in this conversion.

Trident Lifeline Ltd has been recognized with a prestigious award for 'Outstanding Contribution to India's Pharmaceutical Exports' by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) for the year 2024-25. The award ceremony will take place on September 7, 2026, during the 12th Edition of the International Pharmaceutical Exhibition at Pragati Maidan, New Delhi.

Trident Lifeline Ltd announced the outcome of its Board Meeting held on August 26, 2026. The Board approved the Board's Report for the financial year ended March 31, 2026, along with its annexures. Additionally, the draft notice for the 13th Annual General Meeting (AGM), scheduled for September 26, 2026, was approved. The company also announced that the Register of Members and Share Transfer books will be closed from September 19 to September 26, 2026, for the AGM. CS Mehul Amareliya was appointed as the Scrutinizer for the e-voting process. The reappointment of Mr. Hardik Jigishkumar Desai, who retires by rotation, was recommended for member approval.

Trident Lifeline Ltd announced the outcome of its Board Meeting held on August 26, 2026. The board approved the Board's Report for the financial year ended March 31, 2026, and the Draft Notice for the 13th Annual General Meeting (AGM) scheduled for September 26, 2026. The register of members and share transfer books will be closed from September 19 to September 26, 2026, for the AGM. CS Mehul Amareliya was appointed as the scrutinizer for the e-voting process. Additionally, the reappointment of Mr. Hardik Jigishkumar Desai, who retires by rotation, was recommended for member approval.

Trident Lifeline Limited has announced that its 13th Annual General Meeting (AGM) will be held on Saturday, September 26, 2026, at 04:00 p.m. via Video Conferencing. The Board of Directors, in a meeting held on August 26, 2026, approved the Board's Report for the financial year ended March 31, 2026, and the draft notice for the AGM. The Register of Members and Share Transfer books will be closed from September 19 to September 26, 2026, for the AGM. CS Mehul Amareliya has been appointed as the Scrutinizer. The Board also recommended the reappointment of Mr. Hardik Jigishkumar Desai, who retires by rotation.

Trident Lifeline Ltd has been featured in India Pharma Outlook, a prominent pharmaceutical industry magazine. This recognition highlights the company's growth, capabilities, and contributions to the pharmaceutical sector. The feature delves into Trident Lifeline's journey, its core business strengths, and its strategic initiatives. The digital edition of the magazine is accessible via a provided link, offering insights into the company's standing within the industry.